Anebulo Pharmaceuticals share price logo

Anebulo Pharmaceuticals

OTC: ANEB

$0.31

-0.01

(-3.13%)

as on

Anebulo Pharmaceuticals Stock Performance

as on October 9, 2026 at 12:44 am IST

  • $0.31
    $0.31
  • 52 Week's Low

    52 Week's High

    $0.00
    $2.85
    downward going graph

    99.87%

    Downside

    819.35%

    Upside

    downward going graph

Anebulo Pharmaceuticals share price movements today

Previous Close
$0.32
Open
$0.31
Volume
100.0
Market Cap
$13.1M
Day's Low - High
$0.31 - $0.31
52 Week Low - High
$0.00 - $2.85

Anebulo Pharmaceuticals Historical Returns

1 Month Return
-13.26 %
3 Month Return
-7.85 %
1 Year Return
-86.7 %
3 Year Return
-89.53 %
5 Year Return
-95.29 %

Anebulo Pharmaceuticals Stock Fundamentals & Key Indicators

Check Anebulo Pharmaceuticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$13.1M

EPS (TTM)

-0.1942

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.09

Industry PE ratio

-4.16

PEG Ratio

-0.05

EBITDA

-7.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-64.46%

Anebulo Pharmaceuticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anebulo Pharmaceuticals with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$13.1M-95.29%-2.090.00%0.00%
StrongBuy$128.2B181.24%29.1986.04%0.00%
StrongBuy$30.0B10.23%36.7979.72%0.00%
StrongBuy$41.4BNA26.3387.82%0.00%
Buy$76.1B34.46%17.7284.86%0.50%

Stock Returns calculator for Anebulo Pharmaceuticals Stock including INR - Dollar returns

The Anebulo Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Anebulo Pharmaceuticals investment value today

Current value as on today

₹14,507

Returns

-₹85,493

(-85.49%)

Returns from Anebulo Pharmaceuticals Stock

-₹86,695 (-86.7%)

Dollar Impact

₹1,202 (+1.2%)

Analyst Recommendation on Anebulo Pharmaceuticals Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Anebulo Pharmaceuticals. Average target price of $3

Anebulo Pharmaceuticals Share Price Target

Get share price movements and forecasts by analysts on Anebulo Pharmaceuticals.

What analysts predicted

89.67%UPSIDE

Target Price

$3

Current Price

$0.31

Analyzed by

9 Analysts

Target

$3.00

Anebulo Pharmaceuticals target price $3, a slight upside of 89.67% compared to current price of $0.31. According to 9 analysts rating.

Anebulo Pharmaceuticals Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-2
-2
-1
-1
-2
-2
-1
-2
-2
-2
EBITDA
0
-2
-1
-1
-2
-2
-1
-2
-2
-1
Interest Expense
-
0
0
0
0
0
0
0
0
0
Depreciation
2
0
-
-
0
0
0
-
0
-
Income Before Tax
-2
-2
-1
-1
-2
-2
-1
-2
-2
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-2
-1
-1
-2
-2
-1
-2
-2
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Anebulo Pharmaceuticals Annual Profit & Loss

All numbers in Millions USD

Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
0
-3
-6
-11
-8
-9
EBITDA
0
-30
-6
-11
-7
-7
Interest Expense
0
0
-
-
0
0
Depreciation
-
-
-
-
0
0
Income Before Tax
0
-30
-6
-11
-8
-8
Income Tax Expense
-
-
-
-
-
-
Net Income
0
-30
-6
-11
-8
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Anebulo Pharmaceuticals Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-2
-2
-1
-1
-2
-2
-1
-2
-2
-1
Operating Cash Flow
-2
-1
-1
-2
-1
-1
-1
-1
-1
-1
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
0
-
-
-
15
0
-
-
-
Change in Cash
-2
-1
-1
-2
-1
13
-1
-1
-1
-1

Anebulo Pharmaceuticals Annual Cash Flow

All numbers in Millions USD

Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
0
-30
-6
-11
-8
-8
Operating Cash Flow
0
-4
-5
-9
-8
-6
Investing Cash Flow
-
-
-
-
-
-
Financing Cash Flow
3
21
-
6
0
14
Change in Cash
3
16
-5
-3
-8
8

Global Institutional Holdings in Anebulo Pharmaceuticals

Check out the Institutions with significant holdings in Anebulo Pharmaceuticals.

Funds
Holdings
Fidelity Concord Street Trust
0.30%

Insights on Anebulo Pharmaceuticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 144.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 33.8% return, outperforming this stock by 92.4%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ANEB stock has moved down by -54.3%

About Anebulo Pharmaceuticals

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company’s lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.
OrganisationAnebulo Pharmaceuticals
Headquarters1017 Ranch Road 620 South, Lakeway, TX, 78734, US
IndustryBiotechnology
CEORichard Anthony Cunningham

Key Management of Anebulo Pharmaceuticals

Name

Title

Dr. Joseph F. Lawler M.D., Ph.D.

Founder & Chairman

Mr. Richard Anthony Cunningham

CEO & Director

Mr. Daniel V. George

Acting CFO & Secretary

Dr. Kenneth C. Cundy Ph.D.

Chief Scientific Officer

FAQs

What is Anebulo Pharmaceuticals share price today?

Anebulo Pharmaceuticals share price today is $0.31 as on at the close of the market. Anebulo Pharmaceuticals share today touched a day high of $0.31 and a low of $0.31.

What is the 52 week high and 52 week low for Anebulo Pharmaceuticals share?

Anebulo Pharmaceuticals share touched a 52 week high of $2.85 on and a 52 week low of $0.00 on . Anebulo Pharmaceuticals stock price today i.e. is closed at $0.31,which is 89.12% down from its 52 week high and 77400.00% up from its 52 week low.

What is Anebulo Pharmaceuticals's market capitalisation today?

Anebulo Pharmaceuticals market capitalisation is $0.00T as on .

How to invest in Anebulo Pharmaceuticals Stock (ANEB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anebulo Pharmaceuticals on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Anebulo Pharmaceuticals Stock (ANEB) from India?

Indian investors can start investing in Anebulo Pharmaceuticals (ANEB) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Anebulo Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on ). Based on Anebulo Pharmaceuticals share’s latest price of $0.31 as on October 8, 2026 at 7:14 pm IST, you will get 32.2581 shares of Anebulo Pharmaceuticals. Learn more about fractional shares .

What are the returns that Anebulo Pharmaceuticals has given to Indian investors in the last 5 years?

Anebulo Pharmaceuticals stock has given -95.29% share price returns and 28.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?